Market report
Pharmaceutical tenders in Czechia — market report, September 2026
Pharmaceutical tenders in Czechia in September 2026: 11,666 tenders published (+17% month on month, +41% year on year), estimated at €1,017,493,194 in total, and 11,468 contracts awarded (+16% month on month, +35% year on year), worth €144,104,478 (awarded value). Buyers with the most tenders: Fakultní nemocnice Olomouc (915), Institut klinické a experimentální medicíny (911) and Krajská zdravotní, a.s. (807); most contracts won: Janssen-Cilag s.r.o. (302), ROCHE s.r.o. (299) and Takeda Pharmaceuticals Czech Republic s.r.o. (253). On average 3.1 bids per contract; 51% of contracts had a single bid. Report made on 27 October 2026.
- Tenders published
- 11,666
- Contracts awarded
- 11,468
- Contract value awarded
- €144,104,478
- Bids per contract
- 3.1
The highlighted bar is September 2026. Hover a bar for its figure; the table below has every value.
| Figure | September 2026 | August 2026 | Change | September 2025 | Change |
|---|---|---|---|---|---|
| Tenders published | 11,666 | 9,997 | +17% | 8,248 | +41% |
| Estimated value | €1,017,493,194 | €74,609,185 | +1,264% | €37,093,942 | +2,643% |
| Buyers | 84 | 82 | +2% | 80 | +5% |
| Contracts awarded | 11,468 | 9,892 | +16% | 8,487 | +35% |
| Contract value (awarded) | €144,104,478 | €63,797,904 | +126% | €48,508,780 | +197% |
| Winners | 391 | 369 | +6% | 375 | +4% |
| Bids per contract | 3.1 | 2.5 | — | 14.4 | — |
| Single-bid contracts | 51% | 61% | — | 46% | — |
Buyers with the most tenders
Companies with the most contracts
| # | Winners | Contracts |
|---|---|---|
| 1 | Janssen-Cilag s.r.o. | 302 |
| 2 | ROCHE s.r.o. | 299 |
| 3 | Takeda Pharmaceuticals Czech Republic s.r.o. | 253 |
| 4 | AbbVie s.r.o. | 228 |
| 5 | ResMed CZ s.r.o. | 206 |
| 6 | ViaPharma s.r.o. | 197 |
| 7 | Avenier a.s. | 194 |
| 8 | Amgen s.r.o. | 171 |
| 9 | BAYER s.r.o. | 148 |
| 10 | Merck Sharp & Dohme s.r.o. | 141 |
Where the tenders were
Procedures
The report's aggregates: the figures, the comparisons and the top lists by name and count.
All reports: Medicines and pharmaceuticals
Questions and answers
- How many pharmaceutical tenders were published in Czechia in September 2026?
- 11,666 (by 84 buyers); for comparison, August 2026: 9,997, September 2025: 8,248.
- Who won the most pharmaceutical tenders in Czechia in September 2026?
- By number of contracts: Janssen-Cilag s.r.o. (302), ROCHE s.r.o. (299), Takeda Pharmaceuticals Czech Republic s.r.o. (253), AbbVie s.r.o. (228) and ResMed CZ s.r.o. (206); 391 companies won contracts in all.
- Which buyers published the most pharmaceutical tenders in September 2026?
- Fakultní nemocnice Olomouc (915), Institut klinické a experimentální medicíny (911), Krajská zdravotní, a.s. (807), Fakultní nemocnice Brno (653) and Fakultní Thomayerova nemocnice (479).
- How competitive were pharmaceutical tenders in Czechia in September 2026?
- On average 3.1 bids per contract (141 contracts with a known number of bids); 51% of contracts had a single bid.
- What were the contracts worth in September 2026?
- €144,104,478 (awarded value, 11,468 contracts); median about €97,000.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.